This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
Mark Your Calendar for BPI Europe 2025
12-15 May 2025Congress Center Hamburg, Germany

DFE Pharma


DFE Pharma, a world leader in providing essential excipients for inhalation and oral solid dose applications for decades, has expanded its presence into the biopharmaceutical market.

Discover our BioHale® excipients for biologics to stabilize biopharmaceutical formulations, BioHale®Sucrose and BioHale Trehalose®, and benefit from:

- Uncompromised quality

- cGMP and FDA inspected manufacturing facility o Highest purity of excipients with very low endotoxin level

- Multi-compendial compliance (Ph. Eur., USP-NF, JP, ChP)

- Expert support

  • Technical expertise
  • Excipient information package available
  • Quality and regulatory support

- Security of supply

- Local stocks

- Capacity to adapt to volatile demand

- Business Continuity Plan in place

In addition, we offer a purification step integrated into manufacturing process to enhance the product quality and consistency, strengthening supply chain security as product quality is not affected by raw material variations.

To learn more please visit